External beam radiotherapy for synchronous rectal and prostatic tumors.

W. Siu, D. S. Kapp, S. M. Wren, C. King, M. K. Terris

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Two patients were diagnosed with large rectal tumors and localized prostate cancer. The prostate-specific antigen level at diagnosis was 7.9 ng/mL and 9.0 ng/mL in the 2 patients. Knowledge of the presence of both tumors and their close proximity allowed creation of a modified three-dimensional conformal radiotherapy plan to treat both tumors. The patients had no evidence of rectal tumor recurrence and their prostate-specific antigen level was 0.5 ng/mL and 0.7 ng/mL at 1 and 2 years after therapy, respectively. We conclude that efficient, effective pelvic irradiation can be designed for synchronous rectal and prostate malignancies.

Original languageEnglish (US)
Number of pages1
JournalUrology
Volume57
Issue number4
StatePublished - Apr 2001

Fingerprint

Rectal Neoplasms
Radiotherapy
Prostate-Specific Antigen
Conformal Radiotherapy
Neoplasms
Prostate
Prostatic Neoplasms
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

External beam radiotherapy for synchronous rectal and prostatic tumors. / Siu, W.; Kapp, D. S.; Wren, S. M.; King, C.; Terris, M. K.

In: Urology, Vol. 57, No. 4, 04.2001.

Research output: Contribution to journalArticle

Siu, W, Kapp, DS, Wren, SM, King, C & Terris, MK 2001, 'External beam radiotherapy for synchronous rectal and prostatic tumors.', Urology, vol. 57, no. 4.
Siu, W. ; Kapp, D. S. ; Wren, S. M. ; King, C. ; Terris, M. K. / External beam radiotherapy for synchronous rectal and prostatic tumors. In: Urology. 2001 ; Vol. 57, No. 4.
@article{ad41fadb23fe422f87b123ef1735691e,
title = "External beam radiotherapy for synchronous rectal and prostatic tumors.",
abstract = "Two patients were diagnosed with large rectal tumors and localized prostate cancer. The prostate-specific antigen level at diagnosis was 7.9 ng/mL and 9.0 ng/mL in the 2 patients. Knowledge of the presence of both tumors and their close proximity allowed creation of a modified three-dimensional conformal radiotherapy plan to treat both tumors. The patients had no evidence of rectal tumor recurrence and their prostate-specific antigen level was 0.5 ng/mL and 0.7 ng/mL at 1 and 2 years after therapy, respectively. We conclude that efficient, effective pelvic irradiation can be designed for synchronous rectal and prostate malignancies.",
author = "W. Siu and Kapp, {D. S.} and Wren, {S. M.} and C. King and Terris, {M. K.}",
year = "2001",
month = "4",
language = "English (US)",
volume = "57",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - External beam radiotherapy for synchronous rectal and prostatic tumors.

AU - Siu, W.

AU - Kapp, D. S.

AU - Wren, S. M.

AU - King, C.

AU - Terris, M. K.

PY - 2001/4

Y1 - 2001/4

N2 - Two patients were diagnosed with large rectal tumors and localized prostate cancer. The prostate-specific antigen level at diagnosis was 7.9 ng/mL and 9.0 ng/mL in the 2 patients. Knowledge of the presence of both tumors and their close proximity allowed creation of a modified three-dimensional conformal radiotherapy plan to treat both tumors. The patients had no evidence of rectal tumor recurrence and their prostate-specific antigen level was 0.5 ng/mL and 0.7 ng/mL at 1 and 2 years after therapy, respectively. We conclude that efficient, effective pelvic irradiation can be designed for synchronous rectal and prostate malignancies.

AB - Two patients were diagnosed with large rectal tumors and localized prostate cancer. The prostate-specific antigen level at diagnosis was 7.9 ng/mL and 9.0 ng/mL in the 2 patients. Knowledge of the presence of both tumors and their close proximity allowed creation of a modified three-dimensional conformal radiotherapy plan to treat both tumors. The patients had no evidence of rectal tumor recurrence and their prostate-specific antigen level was 0.5 ng/mL and 0.7 ng/mL at 1 and 2 years after therapy, respectively. We conclude that efficient, effective pelvic irradiation can be designed for synchronous rectal and prostate malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0035318085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035318085&partnerID=8YFLogxK

M3 - Article

C2 - 11306416

AN - SCOPUS:0035318085

VL - 57

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -